 |
|||||
| lose weight | |||||
| NEWS | |||||
|
Makers of GLP-1 drugs ordered to add warnings about rare eye condition that can lead to blindness
The US Food and Drug Administration says Ozempic, Wegovy, and other weight-loss drugs must have labels about the condition, known as NAION.
|
|||||
|
The FDA now says Ozempic, Zepbound and other GLP-1 drugs have a possible risk of vision loss
... lose weight. That said, taking a GLP-1 isn't the only risk factor for NAION. Some patients already have an elevated risk, including those who have ...
|
|||||
| See more results | Edit this alert | |||||
| You have received this email because you have subscribed to Google Alerts. |
 Receive this alert as RSS feed |
|
Send Feedback
|
